Federal contract awards: NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology))
Past federal contracts, straight from USAspending.gov. Use them to price your bid, size up the competition and find the agencies that buy what you sell.
Showing contracts that started in the last 12 months (first 2 pages). Register free to browse every page.
146contracts awarded
$487,163median value
$111,561 – $1,292,260typical range (P25–P75)
2.5average offers received
$687,848,142total obligated
Agencies that buy the most
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 146 | $687,848,142 |
Top winners
| Company | Contracts | Obligated |
|---|---|---|
| ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE) | 1 | $263,613,186 |
| SHIONOGI INC | 1 | $156,103,541 |
| KALEO, INC. | 1 | $96,058,494 |
| VERICEL CORPORATION | 1 | $34,880,933 |
| OXOS MEDICAL INC | 1 | $9,574,161 |
| BATTELLE MEMORIAL INSTITUTE | 4 | $9,372,823 |
| ALPHA GENESIS INC | 1 | $8,092,003 |
| SANOFI VACCINES US INC. | 2 | $6,716,278 |
| RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 1 | $6,515,098 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | 1 | $5,617,704 |
Contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOI…
75A50126C00010 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Glen Allen, VA · Offers: 3 |
KALEO, INC. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$96,058,494 Potential value: $340,910,795 |
Sep 30, 2026 Ends: Dec 31, 2034 |
| MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
75A50126F61014 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Swiftwater, PA |
SANOFI VACCINES US INC. | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response |
$6,018,839 Potential value: $19,449,130 |
Sep 30, 2026 Ends: Sep 29, 2027 |
| EO 14398 - RISK ASSESSMENT
75D30126P21609 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Cheshire, MA · Offers: 1 |
SCITOVATION, LLC | Department of Health and Human Services Centers for Disease Control and Prevention |
$337,915 | Sep 30, 2026 Ends: Sep 29, 2029 |
| BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRI…
75F40126C00055 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Houston, TX · Offers: 1 |
THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | Department of Health and Human Services Food and Drug Administration |
$752,304 | Sep 30, 2026 Ends: Sep 29, 2028 |
| BAA FY26C1CP12: FDA, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), ESTIMATION OF IN-VIVO TISSUE PROPERTIES USING CLINICAL MR THERMOMETR…
75F40126C00056 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Binghamton, NY · Offers: 1 |
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | Department of Health and Human Services Food and Drug Administration |
$2,456,000 | Sep 30, 2026 Ends: Sep 29, 2029 |
| TO ADVANCE THE DEVELOPMENT, EVALUATION, AND PREDICTIVE MODELING OF LEVONORGESTREL INTRAUTERINE SYSTEMS (LNG-IUSS) BY INTEGRATING ACCELERATED…
75F40126C00059 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1 |
UNIVERSITY OF CONNECTICUT | Department of Health and Human Services Food and Drug Administration |
$511,219 Potential value: $789,844 |
Sep 30, 2026 Ends: Sep 29, 2028 |
| TO CONDUCT AND DEFINE THE TECHNICAL AND PROGRAMMATIC REQUIREMENTS FOR A THREE-YEAR, MULTI-INSTITUTIONAL RESEARCH AND DEVELOPMENT EFFORT TO R…
75F40126C00060 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1 |
UNIVERSITY OF TEXAS AT AUSTIN | Department of Health and Human Services Food and Drug Administration |
$688,145 Potential value: $990,864 |
Sep 30, 2026 Ends: Sep 29, 2028 |
| THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FOR…
75F40126C00063 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1 |
SIMULATIONS PLUS INC | Department of Health and Human Services Food and Drug Administration |
$575,554 Potential value: $1,650,102 |
Sep 30, 2026 Ends: Dec 29, 2027 |
| BAA CONTRACT- FY26C2AP9 ADVANCED CMC INDEX AND INTELLIGENCE PLATFORM FOR DRUG QUALITY CONTROL, SHORTAGE PREDICTION, AND STRATEGIC RESHORING
75F40126C00069 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Minneapolis, MN · Offers: 1 |
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC | Department of Health and Human Services Food and Drug Administration |
$634,642 | Sep 30, 2026 Ends: Sep 29, 2027 |
| BAA FY26C1CP53: ADVANCING INTEGRATION OF IN VITRO TOPICAL PRODUCT CHARACTERIZATION AND SKIN PERMEATION DATA
75F40126C00071 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Offers: 1 |
CERTARA UK LIMITED | Department of Health and Human Services Food and Drug Administration |
$352,968 Potential value: $1,083,957 |
Sep 30, 2026 Ends: Sep 29, 2029 |
| EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP1 VALID APPROACHES TO INTEGRATING PATIENT SCIENCE INTO MEDICAL DEVICE STUDIES
75F40126C00081 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Durham, NC · Offers: 1 |
DUKE UNIVERSITY | Department of Health and Human Services Food and Drug Administration |
$749,762 | Sep 30, 2026 Ends: Sep 29, 2029 |
| BAA FY26C3AP4: A CROSS-SPECIES IMMUNE ORGAN CHIP REFERENCE FRAMEWORK FOR REGULATORY EVALUATION OF VACCINE AND ANTIVIRAL MEDICAL COUNTERMEASU…
75F40126C00083 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Reno, NV · Offers: 1 |
BOARD OF REGENTS OF NEVADA SYSTEM OF HIGHER EDUCATION | Department of Health and Human Services Food and Drug Administration |
$1,500,000 Potential value: $9,900,000 |
Sep 30, 2026 Ends: Sep 29, 2027 |
| FDA BAA FY26C1CP13 3-YEAR FIRM-FIXED PRICE (FFP) CONTRACT FOR INVESTIGATING THE IMPACT OF DIASTEREOMERS AND SYNTHESIS-RELATED IMPURITIES ON …
75F40126C00087 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Storrs Mansfield, CT · Offers: 1 |
UNIVERSITY OF CONNECTICUT | Department of Health and Human Services Food and Drug Administration |
$1,173,033 Potential value: $2,432,643 |
Sep 30, 2026 Ends: Sep 29, 2027 |
| 3-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1CP2, MECHANISTIC INSIGHT INTO AGGREGATION BEHAVIOR AND PREDICTIVE MODEL…
75F40126C00088 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Storrs Mansfield, CT · Offers: 1 |
UNIVERSITY OF CONNECTICUT | Department of Health and Human Services Food and Drug Administration |
$657,981 Potential value: $1,207,750 |
Sep 30, 2026 Ends: Sep 29, 2028 |
| 5-YEAR FFP CONTRACT FOR RESEARCH AND DEVELOPMENT SERVICES, BAA FY26C1AP28: MECHANISTIC EVALUATION OF ORAL PEPTIDE ABSORPTION USING ORGANOID-…
75F40126C00089 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Orlando, FL · Offers: 1 |
UNIVERSITY OF FLORIDA | Department of Health and Human Services Food and Drug Administration |
$645,503 Potential value: $1,667,347 |
Sep 30, 2026 Ends: Sep 29, 2028 |
| TO PROVIDE RESEARCH AND DEVELOPMENT SERVICES TO DESIGN, DEVELOP, VALIDATE, AND DELIVER AN AI-ASSISTED DIGITAL TWIN PLATFORM FOR PHARMACEUTIC…
75F40126C00093 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1 |
UNIVERSITY OF MASSACHUSETTS LOWELL | Department of Health and Human Services Food and Drug Administration |
$456,721 | Sep 30, 2026 Ends: Sep 29, 2028 |
| BAA FY26C1CP48: A MULTI-AGENT AI SYSTEM FOR HIGH-THROUGHPUT PBPK MODELING: PREDICTING FORMULATION EFFECT ON DRUG ABSORPTION AND HUMAN PHARMA…
75F40126C00107 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · San Francisco, CA · Offers: 1 |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Department of Health and Human Services Food and Drug Administration |
$500,000 | Sep 30, 2026 Ends: Mar 29, 2028 |
| EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE - CORE CLINICAL OUTCOME ASSESS…
75F40126C00112 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Durham, NC · Offers: 1 |
DUKE UNIVERSITY | Department of Health and Human Services Food and Drug Administration |
$1,456,427 | Sep 30, 2026 Ends: Sep 29, 2028 |
| EO 14398 - INTEGRATING PAT TOOLS (E.G., RAMAN SPECTROSCOPY) WITH DIGITAL TWIN MODELING TO CLARIFY THE UNCERTAINTY IN DIRECT CQA CONTROL WITH…
75F40126C00156 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Lowell, MA · Offers: 1 |
UNIVERSITY OF MASSACHUSETTS LOWELL | Department of Health and Human Services Food and Drug Administration |
$861,756 | Sep 30, 2026 Ends: Sep 29, 2028 |
| EO 14398-BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT FOR MODERNIZING OUTCOME DATA FOR OPIOID USE DISORDER (MOD-OUD)
75F40126C00158 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Boston, MA · Offers: 1 |
DIGITAL MEDICINE SOCIETY INC | Department of Health and Human Services Food and Drug Administration |
$948,781 | Sep 30, 2026 Ends: Dec 30, 2027 |
| FIRM FIXED PRICE AWARD TOWARDS ML-POWERED, EFFICIENT AND ROBUST INFERENCE OF AVERAGE AND INDIVIDUAL TREATMENT EFFECTS FOR NOVEL CLINICAL TRI…
75F40126C00181 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Silver Spring, MD · Offers: 1 |
DUKE UNIVERSITY | Department of Health and Human Services Food and Drug Administration |
$1,256,810 | Sep 30, 2026 Ends: Sep 29, 2030 |
| SUNSCREEN ABSORPTION CLINICAL PHARMACOLOGY STUDY
75F40126F19004 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Webster, TX |
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | Department of Health and Human Services Food and Drug Administration |
$1,294,478 | Sep 30, 2026 Ends: Sep 29, 2027 |
| DDI CLINICAL PHARMACOLOGY STUDY
75F40126F19005 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Webster, TX |
TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | Department of Health and Human Services Food and Drug Administration |
$1,592,481 | Sep 30, 2026 Ends: Sep 29, 2027 |
| ISSUANCE OF TASK ORDER FOR THE CARE, BREEDING, AND PROVISON OF SPF MACAQUES. DAP-NCAP-00000188
75N98026F00001 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Yemassee, SC |
ALPHA GENESIS INC | Department of Health and Human Services National Institutes of Health |
$8,092,003 Potential value: $8,492,003 |
Sep 30, 2026 Ends: Sep 12, 2027 |
| EO 14398. MYOCARDIAL INTRAMURAL REMODELING BY TRANSVENOUS TETHER (MIRTH) IMPLANT DESIGN SUPPORT AND FEASIBILITY PROTOTYPES.
75N98026P01701 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) · Bethesda, MD · Offers: 1 |
RESONETICS LLC | Department of Health and Human Services National Institutes of Health |
$275,000 | Sep 30, 2026 Ends: Jun 29, 2027 |
Page 1 of 2Next →
See every page
Free members can browse the full list of the last 12 months of awards.
Register freeSource: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.